DK498387A - Virus-dna-sekvens - Google Patents

Virus-dna-sekvens

Info

Publication number
DK498387A
DK498387A DK498387A DK498387A DK498387A DK 498387 A DK498387 A DK 498387A DK 498387 A DK498387 A DK 498387A DK 498387 A DK498387 A DK 498387A DK 498387 A DK498387 A DK 498387A
Authority
DK
Denmark
Prior art keywords
dna sequence
viral dna
cho cells
virus
recombinant
Prior art date
Application number
DK498387A
Other languages
English (en)
Other versions
DK498387D0 (da
Inventor
Robert Drillien
Daniele Spehner
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of DK498387D0 publication Critical patent/DK498387D0/da
Publication of DK498387A publication Critical patent/DK498387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK498387A 1986-09-23 1987-09-22 Virus-dna-sekvens DK498387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8613272A FR2604183B1 (fr) 1986-09-23 1986-09-23 Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho

Publications (2)

Publication Number Publication Date
DK498387D0 DK498387D0 (da) 1987-09-22
DK498387A true DK498387A (da) 1988-03-24

Family

ID=9339184

Family Applications (1)

Application Number Title Priority Date Filing Date
DK498387A DK498387A (da) 1986-09-23 1987-09-22 Virus-dna-sekvens

Country Status (9)

Country Link
US (1) US5830688A (da)
EP (1) EP0262043B1 (da)
JP (2) JP2683804B2 (da)
AT (1) ATE76099T1 (da)
AU (1) AU598859B2 (da)
CA (1) CA1341242C (da)
DE (1) DE3779032D1 (da)
DK (1) DK498387A (da)
FR (1) FR2604183B1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364773A (en) * 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
AU3776689A (en) * 1988-06-10 1990-01-05 Applied Biotechnology, Inc. Method of selecting for recombinant pox viruses
JP3044062B2 (ja) * 1989-03-08 2000-05-22 ヘルス・リサーチ・インク 組換えポックスウイルス宿主選択系
US5225336A (en) * 1989-03-08 1993-07-06 Health Research Incorporated Recombinant poxvirus host range selection system
US6514502B1 (en) 1999-01-26 2003-02-04 Schering-Plough Veterinary Corporation Propagation of bovine cononavirus in chinese hamster ovary cells
DK3063278T3 (da) * 2013-11-01 2018-06-06 Sementis Ltd Fremstilling af virale vektorer
WO2024003346A1 (en) 2022-06-30 2024-01-04 Bavarian Nordic A/S Mammalian cell line for the production of modified vaccinia virus ankara (mva)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769330A (en) * 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
JPH0795954B2 (ja) * 1982-11-30 1995-10-18 アメリカ合衆国 外来性遺伝子発現のためのポックスウイルス組換え体の製造方法
WO1985005376A1 (fr) * 1984-05-22 1985-12-05 Transgene S.A. Vecteurs d'expression du facteur ix et lignees cellulaires produisant le facteur ix actif

Also Published As

Publication number Publication date
FR2604183B1 (fr) 1988-12-30
EP0262043A1 (fr) 1988-03-30
EP0262043B1 (fr) 1992-05-13
AU598859B2 (en) 1990-07-05
US5830688A (en) 1998-11-03
JPH09206084A (ja) 1997-08-12
CA1341242C (fr) 2001-06-05
JPS63157988A (ja) 1988-06-30
JP2683804B2 (ja) 1997-12-03
FR2604183A1 (fr) 1988-03-25
DK498387D0 (da) 1987-09-22
AU7890687A (en) 1988-05-19
ATE76099T1 (de) 1992-05-15
JP2818836B2 (ja) 1998-10-30
DE3779032D1 (de) 1992-06-17

Similar Documents

Publication Publication Date Title
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
ATE241014T2 (de) Hiv-2 varianten
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
EP0584266A4 (en) CARCINO-EMBRYONIC ANTIGEN EXPRESSING A RECOMBINANT VIRUS AND METHODS OF USE THEREOF.
DE68903165D1 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
DK498387D0 (da) Virus-dna-sekvens
ATE103328T1 (de) Fuer ein glykoprotein des aids-virus kodierende virus-vektoren, vakzin und antikoerper.
LU91303I2 (fr) Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP
NO175153C (no) Polypeptider
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
ATE179428T1 (de) Verfahren zur herstellung von hepatitis antigenen und impfstoffen
ATE103980T1 (de) Das f-protein vom aids-virus enthaltender impfstoff.
ES2100185T3 (es) Secuencia de adnc y deteccion del virus de la hepatitis c.
DK631387D0 (da) Virusvektor
ATE122396T1 (de) Gibbon leukemia virus-rezeptor.
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment